Factors influencing fluoroquinolone resistance.
作者信息
Sahm Daniel F, Thornsberry Clyde, Jones Mark E, Karlowsky James A
出版信息
Emerg Infect Dis. 2003 Dec;9(12):1651-4. doi: 10.3201/eid0912.030168.
Abstract
摘要
相似文献
1
Factors influencing fluoroquinolone resistance.影响氟喹诺酮耐药性的因素。
Emerg Infect Dis. 2003 Dec;9(12):1651-4. doi: 10.3201/eid0912.030168.
2
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
J Chemother. 2004 Apr;16 Suppl 2:3-7. doi: 10.1080/1120009x.2004.11782365.
3
In-vitro activity of levofloxacin (l-ofloxacin), ofloxacin and ciprofloxacin against clinical isolates of Streptococcus pneumoniae obtained in England and Wales.左氧氟沙星（L-氧氟沙星）、氧氟沙星和环丙沙星对在英格兰和威尔士分离出的肺炎链球菌临床菌株的体外活性。
J Antimicrob Chemother. 1996 Nov;38(5):907-8. doi: 10.1093/jac/38.5.907.
4
Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model.体外药代动力学模型中莫西沙星对肺炎链球菌和铜绿假单胞菌的活性及耐药性的产生
Antimicrob Agents Chemother. 2003 Mar;47(3):1088-95. doi: 10.1128/AAC.47.3.1088-1095.2003.
5
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Mar 7;346(10):747-50. doi: 10.1056/NEJMoa012122.
6
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.一项使用金黄色葡萄球菌和铜绿假单胞菌角膜炎分离株对左氧氟沙星、环丙沙星和氧氟沙星进行的体外耐药性研究。
Ophthalmology. 2001 Oct;108(10):1826-9. doi: 10.1016/s0161-6420(01)00724-2.
7
Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.PGE - 9509924、环丙沙星和左氧氟沙星的抗生素后效应、抗生素后亚抑菌浓度效应及亚抑菌效应。
Antimicrob Agents Chemother. 2003 Oct;47(10):3352-6. doi: 10.1128/AAC.47.10.3352-3356.2003.
8
Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin.
J Antimicrob Chemother. 1997 May;39(5):671-2. doi: 10.1093/jac/39.5.671.
9
[Pneumococcus and quinolone resistance].[肺炎球菌与喹诺酮耐药性]
Arch Bronconeumol. 2003 Mar;39(3):97-100. doi: 10.1016/s0300-2896(03)75333-2.
10
Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.吉米沙星与左氧氟沙星对环丙沙星敏感性降低菌株所致豚鼠肺炎球菌肺炎的疗效及药效学研究
Int J Antimicrob Agents. 2003 Jun;21(6):568-73. doi: 10.1016/s0924-8579(03)00059-1.
引用本文的文献
1
Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance-Implications for Antimicrobial Stewardship?对来自29个欧洲经济区国家的ESAC-Net/EARS-Net数据进行分析，以研究抗菌药物使用与耐药性之间的时空关联——对抗菌药物管理有何启示？
Antibiotics (Basel). 2025 Apr 13;14(4):399. doi: 10.3390/antibiotics14040399.
2
Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties.达氟沙星：在治疗中的地位以及微生物学、临床和药理学特性综述
Infect Dis Ther. 2018 Jun;7(2):197-217. doi: 10.1007/s40121-018-0198-x. Epub 2018 Mar 31.
3
Global spread of multiple aminoglycoside resistance genes.多种氨基糖苷类耐药基因的全球传播。
Emerg Infect Dis. 2005 Jun;11(6):951-3. doi: 10.3201/eid1106.040924.
本文引用的文献
1
Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).1998 - 2000年美国耐氟喹诺酮类肺炎链球菌临床分离株的交叉耐药性、亲缘关系及等位基因分析
J Antimicrob Chemother. 2003 Aug;52(2):168-75. doi: 10.1093/jac/dkg309. Epub 2003 Jul 1.
2
Maintaining fluoroquinolone class efficacy: review of influencing factors.维持氟喹诺酮类药物的疗效：影响因素综述
Emerg Infect Dis. 2003 Jan;9(1):1-9. doi: 10.3201/eid0901.020277.
3
Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.对囊性纤维化患者非黏液型铜绿假单胞菌分离株中耐药突变体的选择频率以及左氧氟沙星和环丙沙星的细菌杀灭率的调查。
Int J Antimicrob Agents. 2002 May;19(5):377-82. doi: 10.1016/s0924-8579(02)00017-1.
4
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.2000年加拿大肺炎链球菌临床分离株中的抗菌药物耐药性。
Antimicrob Agents Chemother. 2002 May;46(5):1295-301. doi: 10.1128/AAC.46.5.1295-1301.2002.
5
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Mar 7;346(10):747-50. doi: 10.1056/NEJMoa012122.
6
Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.自1994 - 1995年以来美国肺炎链球菌对氟喹诺酮类药物的耐药性
Antimicrob Agents Chemother. 2002 Mar;46(3):680-8. doi: 10.1128/AAC.46.3.680-688.2002.
7
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.2000年常见分离革兰氏阴性杆菌对氟喹诺酮类药物的敏感性：美国的TRUST和TSN数据。追踪当今美国的耐药情况。监测网络。
Int J Antimicrob Agents. 2002 Jan;19(1):21-31. doi: 10.1016/s0924-8579(01)00466-6.
8
Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.美国肺炎链球菌、流感嗜血杆菌和卡他莫拉菌临床分离株的抗菌药物耐药性区域趋势：1999 - 2000年TRUST监测项目的结果
Clin Infect Dis. 2002 Mar 1;34 Suppl 1:S4-S16. doi: 10.1086/324525.
9
A critical review of the fluoroquinolones: focus on respiratory infections.氟喹诺酮类药物的批判性综述：聚焦于呼吸道感染
Drugs. 2002;62(1):13-59. doi: 10.2165/00003495-200262010-00002.
10
Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.前列腺炎患者长期服用环丙沙星后大肠杆菌对喹诺酮类药物耐药性的分子流行病学及进化情况
J Antimicrob Chemother. 2002 Jan;49(1):55-9. doi: 10.1093/jac/49.1.55.
Zotero 插件